Jeffrey Wager
Chief Executive Officer bei SPEXIS AG
Profil
Jeffrey D.
Wager is the founder of Apeiron Partners LLC, which was founded in 2000.
Dr. Wager is also the founder of Artisan Pharma, Inc., Proterris, Inc...
Dr. Wager's current job(s) include being the Chairman, Chief Executive Officer & MD at Spexis Ltd.
since 2021 and the Chairman & Chief Executive Officer at EnBiotix, Inc. Dr. Wager's education history includes an MBA from The University of Chicago and a doctorate from Rush Medical College.
Aktive Positionen von Jeffrey Wager
| Unternehmen | Position | Beginn |
|---|---|---|
| SPEXIS AG | Chief Executive Officer | 31.03.2022 |
EnBiotix, Inc.
 EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Chief Executive Officer | - |
Proterris, Inc.
 Proterris, Inc. Pharmaceuticals: MajorHealth Technology Proterris, Inc. manufactures applications of low-dose carbon monoxide. It develops carbon monoxide for delayed graft function in renal transplant recipients and idiopathic pulmonary fibrosis. The company was founded by Jeffrey Wager and Joseph Wager and is headquartered in Boston, MA. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Jeffrey Wager
| Unternehmen | Position | Ende |
|---|---|---|
Apeiron Partners LLC
 Apeiron Partners LLC Investment ManagersFinance Apeiron Partners LLC provides investment advice. The private company is based in Boston, MA. The company was founded by Jeffrey D. Wager. | Founder | - |
Artisan Pharma, Inc.
 Artisan Pharma, Inc. Hospital/Nursing ManagementHealth Services Artisan Pharma, Inc. provides critical-care and hospital-based therapeutics to patients. The firm focuses on the clinical development of drugs in the field of critical care therapeutics throughout the world. The company was founded by Kazuhisa Tsuruta in 2006 and is headquartered in Waltham, MA. | Chief Executive Officer | - |
Ausbildung von Jeffrey Wager
| The University of Chicago | Masters Business Admin |
| Rush Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SPEXIS AG | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Artisan Pharma, Inc.
Artisan Pharma, Inc. Hospital/Nursing ManagementHealth Services Artisan Pharma, Inc. provides critical-care and hospital-based therapeutics to patients. The firm focuses on the clinical development of drugs in the field of critical care therapeutics throughout the world. The company was founded by Kazuhisa Tsuruta in 2006 and is headquartered in Waltham, MA. | Health Services |
Apeiron Partners LLC
Apeiron Partners LLC Investment ManagersFinance Apeiron Partners LLC provides investment advice. The private company is based in Boston, MA. The company was founded by Jeffrey D. Wager. | Finance |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | Health Services |
Proterris, Inc.
Proterris, Inc. Pharmaceuticals: MajorHealth Technology Proterris, Inc. manufactures applications of low-dose carbon monoxide. It develops carbon monoxide for delayed graft function in renal transplant recipients and idiopathic pulmonary fibrosis. The company was founded by Jeffrey Wager and Joseph Wager and is headquartered in Boston, MA. | Health Technology |
